As of 2025-07-10, the Relative Valuation of Solid Biosciences Inc (SLDB) is (24.40) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.52 USD, the upside of Solid Biosciences Inc based on Relative Valuation is -542.1%.
The range of the Relative Valuation is (18.59) - (33.75) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.8x - 18.7x | 13.3x |
| Forward P/E multiples | 10.3x - 21.3x | 13.8x |
| Fair Price | (18.59) - (33.75) | (24.40) |
| Upside | -436.7% - -711.4% | -542.1% |
| Date | P/E |
| 2025-07-03 | -2.79 |
| 2025-07-02 | -2.70 |
| 2025-07-01 | -2.55 |
| 2025-06-30 | -2.70 |
| 2025-06-27 | -2.62 |
| 2025-06-26 | -2.67 |
| 2025-06-25 | -2.63 |
| 2025-06-24 | -2.70 |
| 2025-06-23 | -2.50 |
| 2025-06-20 | -2.66 |
| 2025-06-18 | -2.58 |
| 2025-06-17 | -2.56 |
| 2025-06-16 | -2.79 |
| 2025-06-13 | -2.50 |
| 2025-06-12 | -2.54 |
| 2025-06-11 | -2.56 |
| 2025-06-10 | -2.68 |
| 2025-06-09 | -2.57 |
| 2025-06-06 | -2.52 |
| 2025-06-05 | -2.36 |
| 2025-06-04 | -2.13 |
| 2025-06-03 | -1.94 |
| 2025-06-02 | -1.97 |
| 2025-05-30 | -1.78 |
| 2025-05-29 | -1.83 |
| 2025-05-28 | -1.81 |
| 2025-05-27 | -1.69 |
| 2025-05-23 | -1.56 |
| 2025-05-22 | -1.60 |
| 2025-05-21 | -1.50 |
| 2025-05-20 | -1.64 |
| 2025-05-19 | -1.61 |
| 2025-05-16 | -1.54 |
| 2025-05-15 | -1.44 |
| 2025-05-14 | -1.42 |
| 2025-05-13 | -1.55 |
| 2025-05-12 | -1.61 |
| 2025-05-09 | -1.53 |
| 2025-05-08 | -1.54 |
| 2025-05-07 | -1.44 |
| 2025-05-06 | -1.87 |
| 2025-05-05 | -2.35 |
| 2025-05-02 | -2.39 |
| 2025-05-01 | -2.03 |
| 2025-04-30 | -1.84 |
| 2025-04-29 | -1.69 |
| 2025-04-28 | -1.79 |
| 2025-04-25 | -1.83 |
| 2025-04-24 | -2.04 |
| 2025-04-23 | -1.98 |